This Extension of Time was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on July 27, 2022 and assigned serial number 88237412 by the TTAB.

Plaintiff:
Iovance Biotherapeutics, Inc. represented by CARLA B. OAKLEY of MORGAN, LEWIS & BOCKIUS LLP.

Plaintiff:
NOVARTIS CORPORATION represented by MAURY M. TEPPER, III of TEPPER & EYSTER, PLLC.

Prosecution History:
July 27, 2022 – FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE
July 27, 2022 – EXT GRANTED
August 04, 2022 – FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE
August 04, 2022 – EXT GRANTED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.